WFA
AGIO icon

Wipfli Financial Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Wipfli Financial Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6K Buy
+228
New +$6.12K ﹤0.01% 1997

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wipfli Financial Advisors's AGIO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2022: 228 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #1997 among its holdings.

168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

  • Wipfli Financial Advisors held 228 shares of Agios Pharmaceuticals worth $6K as of Q3 2022.
  • Agios Pharmaceuticals was a new Wipfli Financial Advisors position in Q3 2022.
  • Agios Pharmaceuticals made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1997 holding.
  • 168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.